Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 3

Lessons from the current European Heart Rhythm Association consensus document on screening for atrial fibrillation

Pages
222–224
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reviewed not onlythe methods and tools but also the role of health care professionals and patient organizations in addition to cost-effectiveness issues.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this paper, we reviewed the atrial fibrillation screening strategies in a stepwise manner and discussed the uncertainties in the assessment ofthe need for anticoagulation in light of the recently published European Heart Rhythm Association consensus document.
📊
Key Findings & Data:In this paper, we reviewed the atrial fibrillation screening strategies in a stepwise manner and discussed the uncertainties in the assessment ofthe need for anticoagulation in light of the recently published European Heart Rhythm Association consensus document.
💡
Conclusion & Impact:We reviewed not onlythe methods and tools but also the role of health care professionals and patient organizations in addition to cost-effectiveness issues.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In this paper, we reviewed the atrial fibrillation screening strategies in a stepwise manner and discussed the uncertainties in the assessment ofthe need for anticoagulation in light of the recently published European Heart Rhythm Association consensus document. We reviewed not onlythe methods and tools but also the role of health care professionals and patient organizations in addition to cost-effectiveness issues.

🔖

Cite This Article

ÖZCAN, E. E., GÖRENEK, B. (2018). Lessons from the current European Heart Rhythm Association consensus document on screening for atrial fibrillation. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 3, 222–224. https://ajindex.com/articles/357827

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-9. [CrossRef] Gorenek B Chair, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, et al. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 2017; 19: 1556-78. [CrossRef] Van Gelder IC, Healey JS, Crijns HJGM, Wang J, Hohnloser SH, Gold MR, et al. Duration of device-detected subclinical atrial fibrillation and occurence of stroke in ASSERT. Eur Heart J 2017; 38: 1339-44. [CrossRef] Boriani G, Pettorelli D. Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation. Vascul Pharmacol 2016; 83: 26-35. [CrossRef] Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J, et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 2012; 14: 278-93. [CrossRef] Meziane N, Webster JG, Attari M, Nimunkar AJ. Dry electrodes for electrocardiography. Physiol Meas 2013; 34: R47-69. [CrossRef] Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol 2013; 36: 328-33. National Institute for Health and Care Excellence NICE. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring or hypertension. Medical Technology Guidance, Published NICE 16th January 2013. Nice.org.uk/guidance/ mtg13. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18: 1609-78.
  2. Fauchier L, Clementy N, Pelade C, Collignon C, Nicolle E, Lip GY. Patients with Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study. Stroke 2015; 46: 2432-7. [CrossRef] Brunner KJ, Bunch TJ, Mullin CM, May HT, Bair TL, Elliot DW, et al. Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring. Mayo Clin Proc 2014; 89: 1498-505. [CrossRef] Alonso